Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Aura Biosciences
AURA
$725M
| $401K | ﹤0.01% |
64,932
-3,619
| -5% | -$23.7K |
|
3877
Aldeyra Therapeutics
ALDX
$92.9M
| $400K | ﹤0.01% |
76,644
-19,004
| -20% | -$99.1K |
|
3878
Direxion Daily FTSE China Bull 3X ETF
YINN
$782M
| $400K | ﹤0.01% |
7,369
| – | – |
|
3879
FVCBankcorp
FVCB
$335M
| $400K | ﹤0.01% |
30,819
-474
| -2% | -$6.23K |
|
|
DRUG
3880
Bright Minds Biosciences
DRUG
$719M
| $399K | ﹤0.01% |
6,581
-1,812
| -22% | -$70.3K |
|
3881
LG Display
LPL
$3B
| $399K | ﹤0.01% |
+76,372
| New | +$317K |
|
3882
Entravision Communication
EVC
$1.03B
| $398K | ﹤0.01% |
170,649
-17,766
| -9% | -$43.2K |
|
3883
Capricor Therapeutics
CAPR
$223M
| $397K | ﹤0.01% |
55,093
-75,818
| -58% | -$558K |
|
3884
PUT
SentinelOne
S
$6.53B
| $396K | ﹤0.01% |
22,500
-33,000
| -59% | -$592K |
|
|
BRAG
3885
Bragg Gaming Group
BRAG
$50.6M
| $396K | ﹤0.01% |
130,200
+130,000
| +65,000% | +$459K |
|
3886
First United
FUNC
$285M
| $395K | ﹤0.01% |
10,753
-1,176
| -10% | -$41.4K |
|
|
JBIO
3887
Jade Biosciences
JBIO
$1.2B
| $395K | ﹤0.01% |
45,767
-229,063
| -83% | -$1.87M |
|
3888
Velocity Financial
VEL
$689M
| $394K | ﹤0.01% |
21,701
-12,915
| -37% | -$236K |
|
3889
Health Catalyst
HCAT
$154M
| $394K | ﹤0.01% |
138,086
-17,915
| -11% | -$61.3K |
|
|
BZAI
3890
Blaize Holdings
BZAI
$112M
| $392K | ﹤0.01% |
+113,538
| New | +$404K |
|
3891
NexGen Energy
NXE
$6.06B
| $392K | ﹤0.01% |
43,761
-99,278
| -69% | -$732K |
|
3892
American Coastal Insurance
ACIC
$515M
| $392K | ﹤0.01% |
34,373
-6,897
| -17% | -$75.1K |
|
3893
Criteo S.A. Ordinary Shares
CRTO
$1.1B
| $391K | ﹤0.01% |
17,305
+2,213
| +15% | +$51.8K |
|
3894
Ironwood Pharmaceuticals
IRWD
$696M
| $389K | ﹤0.01% |
297,318
-68,132
| -19% | -$70.5K |
|
3895
CALL
Nasdaq
NDAQ
$52.7B
| $389K | ﹤0.01% |
4,400
| – | – |
|
3896
Safe Bulkers
SB
$795M
| $388K | ﹤0.01% |
87,357
-69,679
| -44% | -$296K |
|
|
NOAH
3897
Noah Holdings
NOAH
$580M
| $387K | ﹤0.01% |
33,348
+25,806
| +342% | +$308K |
|
|
SNWV
3898
SANUWAVE Health Inc
SNWV
$53.1M
| $386K | ﹤0.01% |
10,304
-39,163
| -79% | -$1.45M |
|
3899
loanDepot
LDI
$532M
| $386K | ﹤0.01% |
125,771
-14,308
| -10% | -$33.1K |
|
3900
Target Hospitality
TH
$1.51B
| $384K | ﹤0.01% |
45,316
-30,584
| -40% | -$252K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.